Based on an observation, interviews, record review and review of a facility policy titled, PRESCRIBER MEDICATION ORDERS, the facility failed to address Consultant Pharmacist recommendations for Resident Identifier (RI) #4 in a timely manner. The Nurse Practitioner (NP) responded to the recommendation on 02/05/2024, but the facility failed to implement the NP's response. A month later during the survey on 03/06/2024, RI #4 was observed receiving a one milligram Haldol tablet. This deficient practice affected RI #4, one of five residents sampled for the medication regimen review. Findings include: Review of a facility policy titled, PRESCRIBER MEDICATION ORDERS dated 08/2016, revealed the following: . 2. a. Each medication order is documented in the resident's medical record . …
F756 citations in Alabama
Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2024
Alabama cites F756 less often than its own record predicts
0.45 times the national share — cited less often here than elsewhere.
Of every deficiency written in Alabama in 2024, this is the portion that was F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Alabama surveyors wrote
F756 findings written in Alabama, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
What else Alabama surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction